Annual CFO
-$50.58 M
-$7.65 M-17.83%
December 31, 2023
Summary
- As of February 7, 2025, JANX annual cash flow from operations is -$50.58 million, with the most recent change of -$7.65 million (-17.83%) on December 31, 2023.
- During the last 3 years, JANX annual CFO has fallen by -$46.21 million (-1057.59%).
- JANX annual CFO is now -1221.19% below its all-time high of -$3.83 million, reached on December 31, 2019.
Performance
JANX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$2.23 M
+$7.79 M+77.74%
September 30, 2024
Summary
- As of February 7, 2025, JANX quarterly cash flow from operations is -$2.23 million, with the most recent change of +$7.79 million (+77.74%) on September 30, 2024.
- Over the past year, JANX quarterly CFO has increased by +$9.48 million (+80.95%).
- JANX quarterly CFO is now -140.10% below its all-time high of $5.56 million, reached on March 31, 2021.
Performance
JANX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$36.99 M
+$9.48 M+20.40%
September 30, 2024
Summary
- As of February 7, 2025, JANX TTM cash flow from operations is -$36.99 million, with the most recent change of +$9.48 million (+20.40%) on September 30, 2024.
- Over the past year, JANX TTM CFO has increased by +$15.60 million (+29.66%).
- JANX TTM CFO is now -1886.96% below its all-time high of $2.07 million, reached on March 31, 2021.
Performance
JANX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
JANX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.8% | +81.0% | +29.7% |
| 3 y3 years | -1057.6% | +61.9% | -355.3% |
| 5 y5 years | -1221.2% | -154.7% | -4122.6% |
JANX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -197.9% | at low | at high | +85.2% | -117.9% | +31.9% |
| 5 y | 5-year | -1221.2% | at low | -140.1% | +85.2% | -1887.0% | +31.9% |
| alltime | all time | -1221.2% | at low | -140.1% | +85.2% | -1887.0% | +31.9% |
Janux Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.23 M(-77.7%) | -$36.99 M(-20.4%) |
| Jun 2024 | - | -$10.02 M(-32.5%) | -$46.47 M(-9.8%) |
| Mar 2024 | - | -$14.84 M(+49.9%) | -$51.50 M(+1.8%) |
| Dec 2023 | -$50.58 M(+17.8%) | -$9.90 M(-15.4%) | -$50.58 M(-3.8%) |
| Sep 2023 | - | -$11.71 M(-22.2%) | -$52.59 M(-3.1%) |
| Jun 2023 | - | -$15.05 M(+8.2%) | -$54.29 M(+19.8%) |
| Mar 2023 | - | -$13.91 M(+16.8%) | -$45.31 M(+5.6%) |
| Dec 2022 | -$42.92 M | -$11.91 M(-11.2%) | -$42.92 M(+3.5%) |
| Sep 2022 | - | -$13.41 M(+120.9%) | -$41.49 M(+22.3%) |
| Jun 2022 | - | -$6.07 M(-47.3%) | -$33.93 M(-0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$11.52 M(+9.9%) | -$34.06 M(+100.6%) |
| Dec 2021 | -$16.98 M(+288.6%) | -$10.48 M(+79.0%) | -$16.98 M(+109.0%) |
| Sep 2021 | - | -$5.85 M(-5.6%) | -$8.12 M(+142.3%) |
| Jun 2021 | - | -$6.20 M(-211.5%) | -$3.35 M(-262.0%) |
| Mar 2021 | - | $5.56 M(-441.5%) | $2.07 M(-147.4%) |
| Dec 2020 | -$4.37 M(+14.1%) | -$1.63 M(+50.4%) | -$4.37 M(+59.5%) |
| Sep 2020 | - | -$1.08 M(+38.7%) | -$2.74 M(+65.4%) |
| Jun 2020 | - | -$781.00 K(-10.8%) | -$1.66 M(+89.2%) |
| Mar 2020 | - | -$876.00 K | -$876.00 K |
| Dec 2019 | -$3.83 M | - | - |
FAQ
- What is Janux Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Janux Therapeutics?
- What is Janux Therapeutics annual CFO year-on-year change?
- What is Janux Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Janux Therapeutics?
- What is Janux Therapeutics quarterly CFO year-on-year change?
- What is Janux Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Janux Therapeutics?
- What is Janux Therapeutics TTM CFO year-on-year change?
What is Janux Therapeutics annual cash flow from operations?
The current annual CFO of JANX is -$50.58 M
What is the all time high annual CFO for Janux Therapeutics?
Janux Therapeutics all-time high annual cash flow from operations is -$3.83 M
What is Janux Therapeutics annual CFO year-on-year change?
Over the past year, JANX annual cash flow from operations has changed by -$7.65 M (-17.83%)
What is Janux Therapeutics quarterly cash flow from operations?
The current quarterly CFO of JANX is -$2.23 M
What is the all time high quarterly CFO for Janux Therapeutics?
Janux Therapeutics all-time high quarterly cash flow from operations is $5.56 M
What is Janux Therapeutics quarterly CFO year-on-year change?
Over the past year, JANX quarterly cash flow from operations has changed by +$9.48 M (+80.95%)
What is Janux Therapeutics TTM cash flow from operations?
The current TTM CFO of JANX is -$36.99 M
What is the all time high TTM CFO for Janux Therapeutics?
Janux Therapeutics all-time high TTM cash flow from operations is $2.07 M
What is Janux Therapeutics TTM CFO year-on-year change?
Over the past year, JANX TTM cash flow from operations has changed by +$15.60 M (+29.66%)